Viewing nowEsomeprazole Magnesium 20 mg Tablets
Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Independent Bio Pharmaceutical Co., Ltd.

MFDS item code 201905067 · Approved 2019.07.19 · Insurance code 057700160
Treatment and prevention of reflux, Zollinger-Ellison syndrome, Helicobacter pylori infection, ulcers, rebleeding, and drug-induced gastrointestinal disorders
This medicine is used for the long-term maintenance therapy of gastroesophageal reflux disease and erosive reflux esophagitis to prevent recurrence in patients with esophagitis. It is also effective in treating and preventing recurrence of duodenal ulcers and peptic ulcers caused by Helicobacter pylori infection. Additionally, it aids in the short-term treatment of upper gastrointestinal symptoms that may occur due to the use of non-steroidal anti-inflammatory drugs, as well as in the treatment and prevention of related ulcers. It is used for the treatment of Zollinger-Ellison syndrome and for maintenance therapy after preventing rebleeding from gastric or duodenal ulcers. Therefore, it contributes to the health recovery of patients by being effective in the treatment and improvement of various gastrointestinal diseases.
This medicine should be swallowed with a liquid such as water and must not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis does not heal or symptoms persist, continue taking it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have improved, subsequent recurring symptoms are controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to NSAID administration. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer 20 mg of this medicine with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, heartburn) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. No clinical studies lasting longer than 4 weeks have been conducted. 4) Patients requiring continuous NSAID therapy - Treatment of gastric ulcers associated with NSAID administration: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with NSAID administration: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses greater than 80 mg per day should be divided into two doses. 6) Maintenance therapy following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding due to gastric or duodenal ulcers with intravenous administration. 4. Renal impairment No dose adjustment is necessary. Use with caution because there is limited experience administering this medicine to patients with severe renal failure. 5. Hepatic impairment No dose adjustment is necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this medicine must not exceed 20 mg. 6. Elderly patients No dose adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis does not heal or symptoms persist, continue taking it for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. · Once symptoms have improved, subsequent recurring symptoms are controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurring symptoms in patients at high risk of developing gastric and duodenal ulcers due to NSAID administration. 3. Children under 12 years of age There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be administered to specific patients. First, patients with allergies or hypersensitivity to this drug or its components should not use it. Second, if this medication is to be used with amoxicillin or clarithromycin for Helicobacter pylori eradication, it should not be administered to those with allergies to those antibiotics. Third, patients taking certain heart-related medications or antiviral agents, breastfeeding mothers, and patients with a history of myocardial infarction should not take this medication. This drug contains a coloring agent called Yellow 5, so patients with a history of allergy to this ingredient should use it with caution. Various adverse reactions may occur when using this drug. For example, blood abnormalities, immune system reactions, electrolyte imbalances, neurological symptoms, gastrointestinal symptoms, skin reactions, etc., have been reported. In particular, rare but serious skin disorders, muscle-related problems, and liver dysfunction may occur, so if symptoms appear, immediate consultation with medical personnel is advised. Long-term use of this medication may require regular check-ups and may slightly increase the risk of gastrointestinal infections; thus, if diarrhea symptoms persist, patients should inform their healthcare provider. Moreover, long-term use of this medication may increase the risk of bone fractures, so patients at risk of osteoporosis should be cautious. This medication may interact with other medications; therefore, especially when taken with anticoagulants, antibiotics, antiviral agents, or anticonvulsants, it is essential to follow the expert's instructions. Due to limited safety data regarding use during pregnancy, pregnant women should use this medication with caution, and breastfeeding mothers are advised not to take this drug. In case of overdose, as there is no specific antidote, appropriate treatment should be administered according to the symptoms, and it is crucial to keep it out of reach of children. When using this medication, it is safe to administer the minimum dose and appropriate duration as directed by a healthcare provider.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, confusion, depression, aggression, hallucinations, headache, dizziness, sensory disturbances, drowsiness, taste disorders, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Riel syndrome, acute generalized exanthematous pustulosis, eosinophilia and systemic symptoms associated drug reaction, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial edema, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal malformation, upper abdominal pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, epistaxis, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, abnormal liver function, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, convulsion, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, arthralgia, loss of appetite, apathy, increased appetite, confusion, worsening of depression, hypertonia, anxiety, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, dizziness, visual field defects, sensory disturbances, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, abnormal olfaction, loss of taste, gustatory disturbances, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcers, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal pigmentation, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, gastric fundic polyp, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication can be sensitive to air and moisture, so it should be stored in a tightly closed container. Additionally, it is advisable to keep the drug at normal room temperature, between 1 and 30 degrees Celsius, and not in excessively hot or cold places.
Pale pink oval film-coated tablets
28 tablets (14 tablets/Alu-Alu * 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Independent Bio Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.